Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Inside the growing market for peptides amid concerns over safety

Peptides are being sold on a grey market in Ireland, based on the fact they are not licensed medicines and are advertised by suppliers as not for human consumption

Inside the growing market for peptides amid concerns over safety

Injectable peptides have seen a surge in popularity and promotion online, marketed for fitness, recovery, and cosmetic benefits. However, medical professionals express doubt regarding the claims, citing a lack of scientific evidence. In Ireland, a grey market exists where peptides advertised as not for human consumption are sold.

A recent investigation by Prime Time found that three of four purchased peptide products contained significant impurities, with one sample of Melanotan containing only 40% of the advertised peptide and lacking several other components. Two other samples had substantially less powder than advertised, and all four contained undisclosed bulking agents.

These findings highlight concerns about the quality of products in the emerging peptide market, many of which have not undergone controlled human trials. Peptides encompass a wide range of substances, from established medicines to unapproved drugs and wellness and fitness-related compounds produced in unregulated facilities, often in China.

Despite the lack of scientific backing, peptides have gained popularity among fitness enthusiasts and individuals seeking health and appearance improvements. Some users report positive experiences, while others remain skeptical about the safety and effectiveness of these unregulated substances.

Written by urgent.news from RTE News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at rte.ie →

More in Finance & Markets

More from Thursday 15 October →